Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 215 followers
Latest posts
Last updated 22 days ago
Summary of opinion: Alecensa, 25/04/2024 Positive
22 days ago
Summary of opinion: Alecensa, 25/04/2024 Positive
Summary of opinion: Opdivo, 25/04/2024 Positive
22 days ago
Summary of opinion: Opdivo, 25/04/2024 Positive
Summary of opinion: Triumeq, 25/04/2024 Positive
22 days ago
Summary of opinion: Triumeq, 25/04/2024 Positive
Summary of opinion: Onivyde pegylated liposomal (previously known as Onivyde), 21/03/2024 Positive
about 2 months ago
Summary of opinion: Onivyde pegylated liposomal (previously known as Onivyde), 21/03/2024 Positive
Summary of opinion: Xtandi, 21/03/2024 Positive
about 2 months ago
Summary of opinion: Xtandi, 21/03/2024 Positive
Summary of opinion: Nustendi, 21/03/2024 Positive
about 2 months ago
Summary of opinion: Nustendi, 21/03/2024 Positive
Summary of opinion: Kalydeco, 22/02/2024 Positive
3 months ago
Summary of opinion: Kalydeco, 22/02/2024 Positive
Summary of opinion: Xromi, 22/02/2024 Positive
3 months ago
Summary of opinion: Xromi, 22/02/2024 Positive
Summary of opinion: Retsevmo, 25/01/2024 Positive
4 months ago
Summary of opinion: Retsevmo, 25/01/2024 Positive
Summary of opinion: Apexxnar, 25/01/2024 Positive
4 months ago
Summary of opinion: Apexxnar, 25/01/2024 Positive
Summary of opinion: Abecma, 25/01/2024 Positive
4 months ago
Summary of opinion: Abecma, 25/01/2024 Positive
Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 12, Status: Authorised
4 months ago
Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation...